A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities.
Pharmaceuticals (Basel)
; 16(6)2023 Jun 20.
Article
in En
| MEDLINE
| ID: mdl-37375853
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2023
Document type:
Article